Nasdaq - Delayed Quote USD

Janus Henderson Global Life Sciences Fund (JFNSX)

71.02 +1.14 (+1.63%)
At close: 8:00 PM EDT
Loading Chart for JFNSX
DELL
  • Previous Close 69.88
  • YTD Return 3.39%
  • Expense Ratio 0.98%
  • Category Health
  • Last Cap Gain 24.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating
  • Net Assets 5.1B
  • Beta (5Y Monthly) 0.74
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 34.00%
  • Last Dividend 0.63
  • Inception Date Jan 26, 2018

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Janus Henderson

Fund Family

Health

Fund Category

5.1B

Net Assets

2018-01-26

Inception Date

Performance Overview: JFNSX

Trailing returns as of 5/14/2024. Category is Health.

YTD Return

JFNSX
3.39%
Category
0.00%
 

1-Year Return

JFNSX
7.94%
Category
0.00%
 

3-Year Return

JFNSX
4.45%
Category
0.00%
 

5-Year Return

JFNSX
10.79%
Category
0.00%
 

People Also Watch

Holdings: JFNSX

Top 10 Holdings (37.34% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 6.63%
UNH
UnitedHealth Group Incorporated 5.96%
NOVO-B.CO
Novo Nordisk A/S 4.81%
MRK
Merck & Co., Inc. 3.56%
AZN.L
AstraZeneca PLC 3.56%
ABBV
AbbVie Inc. 3.21%
ABT
Abbott Laboratories 2.49%
SAN.PA
Sanofi 2.46%
VRTX
Vertex Pharmaceuticals Incorporated 2.37%
BSX
Boston Scientific Corporation 2.29%

Sector Weightings

SectorJFNSX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: JFNSX

Research Reports: JFNSX

Top Mutual Funds